Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?
Authors:
- 24 August 2019
- journal article
- editorial
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 26 (4) , 603-605
Abstract
Immune-modifying therapy is the mainstay of treatment for moderate to severe inflammatory bowel disease (IBD) and is associated with an increased risk of infections.1, 2 A recent study found that compared with non-IBD subjects, patients with inflammatory bowel disease are at an increased risk of influenza infection.3 Vaccination against influenza is recommended in patients with IBD by several professional society guidelines and is included as a health care quality measure by the American Gastroenterology Association and Crohn’s and Colitis Foundation.4–6 However, certain immunosuppressive therapies, specifically immunomodulators and/or combinations of biologics with immunomodulators, may impact the generation of protective immune responses after influenza vaccination. Attempts to improve...Keywords
This publication has 23 references indexed in Scilit:
- Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab TherapyInflammatory Bowel Diseases, 2016
- Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trialVaccine, 2016
- Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyJournal of Crohn's and Colitis, 2015
- Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trialJournal of Gastroenterology, 2015
- Immunosenescence: influenza vaccination and the elderlyCurrent Opinion in Immunology, 2014
- Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritisArthritis Research & Therapy, 2014
- Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2013
- Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic reviewVaccine, 2012
- Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel diseaseGut, 2011
- The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccinationAnnals of the Rheumatic Diseases, 2008